BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 28881915)

  • 1. Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Hochhaus A; Saussele S; Rosti G; Mahon FX; Janssen JJWM; Hjorth-Hansen H; Richter J; Buske C;
    Ann Oncol; 2017 Jul; 28(suppl_4):iv41-iv51. PubMed ID: 28881915
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Baccarani M; Dreyling M;
    Ann Oncol; 2010 May; 21 Suppl 5():v165-7. PubMed ID: 20555071
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic myelogenous leukemia: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Baccarani M; Dreyling M;
    Ann Oncol; 2009 May; 20 Suppl 4():105-7. PubMed ID: 19454424
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic myelogenous leukemia: ESMO clinical recommendations for the diagnosis, treatment and follow-up.
    Hochhaus A; Dreyling M;
    Ann Oncol; 2008 May; 19 Suppl 2():ii63-4. PubMed ID: 18456772
    [No Abstract]   [Full Text] [Related]  

  • 5. Treating chronic myeloid leukaemia: NICE guidance.
    Dowling M; Meenaghan T; Kelly M
    Br J Nurs; 2012 Feb 23-Mar 7; 21(4):S16-7. PubMed ID: 22470902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic myeloid leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Baccarani M; Pileri S; Steegmann JL; Muller M; Soverini S; Dreyling M;
    Ann Oncol; 2012 Oct; 23 Suppl 7():vii72-7. PubMed ID: 22997458
    [No Abstract]   [Full Text] [Related]  

  • 7. Evolution of clinical trial endpoints in chronic myeloid leukemia: efficacious therapies require sensitive monitoring techniques.
    Tibes R; Mesa RA
    Leuk Res; 2012 Jun; 36(6):664-71. PubMed ID: 22459332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel large-sized BCR-ABL transcript in a case of chronic myeloid leukaemia characterised by a favourable clinical course.
    De Matteis G; Veneri D; Aprili F; Benati M; Paviati E; Guidi GC; Pizzolo G; Tecchio C
    Ann Hematol; 2013 Mar; 92(3):413-5. PubMed ID: 23053185
    [No Abstract]   [Full Text] [Related]  

  • 9. Good clinical practice in chronic myeloid leukemia: advances and prospects at the Institute of Oncology of Moldova.
    Musteata V
    J BUON; 2010; 15(1):188-9. PubMed ID: 20414949
    [No Abstract]   [Full Text] [Related]  

  • 10. [Guideline for the diagnosis and management in the disease monitoring of patients with Chronic Myeloid Leukemia in China (2014)].
    Huang X;
    Zhonghua Xue Ye Xue Za Zhi; 2014 Aug; 35(8):781-4. PubMed ID: 25152139
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment guidelines of chronic myeloid leukemia].
    Chinese Society of Hematology
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jun; 32(6):426-32. PubMed ID: 21781508
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognosis and therapy in chronic myeloid leukaemia.
    Mehta J; Singhal S; Mehta BC
    J Assoc Physicians India; 1992 Feb; 40(2):130-1. PubMed ID: 1629126
    [No Abstract]   [Full Text] [Related]  

  • 13. New directions for the treatment of chronic myeloid leukaemia.
    Goldman JM
    Drugs; 1995 May; 49(5):651-5. PubMed ID: 7601007
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
    Deininger MW; Shah NP; Altman JK; Berman E; Bhatia R; Bhatnagar B; DeAngelo DJ; Gotlib J; Hobbs G; Maness L; Mead M; Metheny L; Mohan S; Moore JO; Naqvi K; Oehler V; Pallera AM; Patnaik M; Pratz K; Pusic I; Rose MG; Smith BD; Snyder DS; Sweet KL; Talpaz M; Thompson J; Yang DT; Gregory KM; Sundar H
    J Natl Compr Canc Netw; 2020 Oct; 18(10):1385-1415. PubMed ID: 33022644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paediatric-type nodal follicular lymphoma in a child diagnosed with chronic myeloid leukaemia.
    Domínguez-Pinilla N; Martínez-Zamorano E; Campos-Martín Y; Algara Plana P; Ignacio González-Granado L; Zamora Gómez M; Mollejo Villanueva M
    Br J Haematol; 2019 Sep; 186(6):e207-e209. PubMed ID: 31286492
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chronic myeloid leukemia. Current strategies in diagnosis, therapy and follow-up].
    Hochhaus A; Hehlmann R
    Internist (Berl); 1996 Oct; 37(10):1013-21. PubMed ID: 9019445
    [No Abstract]   [Full Text] [Related]  

  • 17. Trends in incidence, primary treatment and survival in chronic myelomonocytic leukaemia: a population-based study of 1359 patients diagnosed in the Netherlands from 1989 to 2012.
    Dinmohamed AG; Brink M; Visser O; Sonneveld P; van de Loosdrecht AA; Jongen-Lavrencic M; de Greef GE
    Br J Haematol; 2015 Nov; 171(3):436-9. PubMed ID: 25854120
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chronic myeloid leukemia].
    Gratwohl A; Favre G
    Rev Med Suisse; 2005 Jun; 1(24):1631-5. PubMed ID: 16028709
    [No Abstract]   [Full Text] [Related]  

  • 19. Point: Is there a best duration of deep molecular response to achieve therapy-free remission in chronic myeloid leukaemia?
    Gale RP; Saglio G
    Br J Haematol; 2021 Jan; 192(1):22-23. PubMed ID: 33169841
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chronic myeloid leukemia. Diagnosis, development and prognosis].
    Tanzer J
    Rev Prat; 1988 Jun; 38(18):1210-6. PubMed ID: 3175491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.